SEC Form D · filed September 4, 2020
Escient Pharmaceuticals Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (27)
Charles Zuker · San Diego, CADirectorAndrew Schwab · San Francisco, CADirectorKevin Raidy · New York, NYDirectorKathleen Glaub · San Diego, CADirectorPeter Hirth · San Diego, CADirectorJeenjoo Kang · San Francisco, CADirectorMarcus Boehm · San Diego, CAExecAlain Baron · San Diego, CAExec · DirectorJason Hafler · Cambridge, MADirectorMatt G. Price · Cincinnati, OHExecBijel Doshi · Reno, NVDirectorAbel Godfrey · Luxembourg, LuxembourgDirectorRandy S. Hurwitz · Los Angeles, CADirectorShane Haag · Baton Rouge, LADirectorMike P. Vanhorn · Joplin, MOExec · DirectorAnton Baranchuk · San Carlos, CADirectorKevin Leary · Reno, NVDirectorFrank Gadams · NORFOLK, VADirectorGilbert G. Schneider · VANCOUVER, British Columbia, CanadaDirectorJohn Ryan · Wallace, IDExecJoaquim Trias · Natick, MADirectorMatthew Boutte · Fair Oaks Ranch, TXDirectorCharles E. Smith · Fair Oaks Ranch, TXDirectorChristopher Watters · Austin, TXExec · DirectorJay Stevens · Marriottsville, MDDirectorMatthew Eitner · New York, NYDirectorPatrick Gallagher · New York, NYDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗